Dr V V S Rajendra Prasad
vidwan id: 169369
Professor,
Vishnu Institute of Pharmaceutical Education and Research
Expertise
- Medicinal Chemistry
Publications
Publications
No publication activity to display at the moment.
Scopus
h-index
10
CrossRef
Citations
218
h-index
9
Google Scholar
Loading Scholar statistics...
Professional Recognition
SIPRA Innovation Award
SIPRA LABS LIMITEDCareer Award for Young Teachers (CAYT)
AICTE IndiaSenior Research Fellowship (SRF) by ICMR
ICMR, Govt of IndiaCommunity & Membership
No Data Found
There is currently nothing to display here.
IPA
APTI
Bio
Extensive training and experience in drug design and discovery, organic synthesis, medicinal and pharmaceutical chemistry. Expertise in operation of modern analytical techniques used in drug discovery and mechanistic studies and modern separation and characterization techniques.
Personal Details
- Male
- Professor , Vishnu Institute of Pharmaceutical Education and Research
- Vishnu Institute of Pharmaceutical Education and Research, Narsapur
Related Profiles
Experts (495+)
View All
Assistant Professor
Assistant Professor
Assistant Professor
Physical Director
Assistant Professor
Assistant Professor
Dr Jyothi Alias Jyotsna Baragi
Assistant Professor
Assistant Professor
Professor
N/A
Organisations (50+)
View All
Assistant Professor
Assistant Professor
Assistant Professor
Assistant Professor
Associate Professor
Assistant Professor
Assistant Professor
Assistant Professor
Assistant Professor
Associate Professor
Co-Authors (8)
Osmania University
JSS Academy of Higher Education & Research
Padmasri Dr. B.V Raju Institute of Technology
Swami Vivekananda Institute of Pharmaceutical Sciences
Vishnu Institute of Pharmaceutical Education and Research
Shri Vishnu College Of Pharmacy
Padmasri Dr. B.V Raju Institute of Technology
Scholarly Work
Development of an affordable test kit for early detection of colon cancer and GIT disorders
Funding Agency: MSME
Principal Investigator
1,458,000
2022 - Ongoing
Nitric oxide releasing Quinilones derivatives as inhibitors of doxorubicine resistance in cancer
Funding Agency: AICTE
PI
1,258,690
2022 - Ongoing
Nitric oxide releasing Quinilones derivatives as inhibitors of doxorubicine resistance in cancer
Funding Agency: AICTE
Principal Investigator
1,275,000
2022 - Ongoing
Development of an affordable test kit for early detection of colon cancer and GIT disorders
Funding Agency: MSME
PI
1,380,000
2022 - 2024
Development of Nitric oxide releasing Quinoline derivatives as inhibitors of doxorubicin resistance in cancer cells
Funding Agency: Department of Science and Technology, Govt. of India
PI
14,000,000
2019 - Ongoing
Nitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells
Funding Agency: SERB
PI
1,328,956
2015 - 2016
Project, structural insights to inhibit epidermal growth factor receptor (EGFR) dimerization & activation: panitumumab induced conformational study
Funding Agency: DBT
PI
3,200,000
2015 - 2019
Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies
Funding Agency: SERB
PI
145,258
2013 - 2014
Design And Synthesis Of Nitric Oxide Donating acridone derivatives as reverters of multidrug resistance (MDR) in cancer cells
Funding Agency: SERB
PI
1,802,000
2012 - 2015
Design, Synthesis of quinazoline tagged Acridones and their cytotoxic studies in drug sensitive, resistant cells
Funding Agency: AICTE
PI
900,000
2012 - 2015
